Controlled colonization of the human gut with a genetically engineered microbial therapeutic.

Saved in:
Bibliographic Details
Title: Controlled colonization of the human gut with a genetically engineered microbial therapeutic.
Authors: Whitaker WR; Novome Biotechnologies, South San Francisco, CA, USA.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA., Russ ZN; Novome Biotechnologies, South San Francisco, CA, USA., Stanley Shepherd E; Novome Biotechnologies, South San Francisco, CA, USA., Popov LM; Novome Biotechnologies, South San Francisco, CA, USA., Louie A; Novome Biotechnologies, South San Francisco, CA, USA., Lam K; Novome Biotechnologies, South San Francisco, CA, USA., Zong DM; Novome Biotechnologies, South San Francisco, CA, USA., Gill CCC; Novome Biotechnologies, South San Francisco, CA, USA., Gehrig JL; Novome Biotechnologies, South San Francisco, CA, USA., Rishi HS; Novome Biotechnologies, South San Francisco, CA, USA., Tan JA; Novome Biotechnologies, South San Francisco, CA, USA., Buness A; Novome Biotechnologies, South San Francisco, CA, USA., Godoy J; Novome Biotechnologies, South San Francisco, CA, USA., Banta D; Novome Biotechnologies, South San Francisco, CA, USA., Jaidka S; Novome Biotechnologies, South San Francisco, CA, USA., Wilson K; Novome Biotechnologies, South San Francisco, CA, USA., Flood J; Novome Biotechnologies, South San Francisco, CA, USA., Bukshpun P; Novome Biotechnologies, South San Francisco, CA, USA., Yocum R; Novome Biotechnologies, South San Francisco, CA, USA., Cook DN; Novome Biotechnologies, South San Francisco, CA, USA., Warsi T; Novome Biotechnologies, South San Francisco, CA, USA., McLean L; Novome Biotechnologies, South San Francisco, CA, USA., Sonnenburg JL; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.; Chan Zuckerberg Biohub, San Francisco, CA, USA.; Center for Human Microbiome Studies, Stanford University School of Medicine, Stanford, CA, USA., DeLoache WC; Novome Biotechnologies, South San Francisco, CA, USA.
Source: Science (New York, N.Y.) [Science] 2025 Jul 17; Vol. 389 (6757), pp. 303-308. Date of Electronic Publication: 2025 Jul 17.
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1095-9203
DOI:10.1126/science.adu8000